HomeCompareVIRI vs SBUX

VIRI vs SBUX: Dividend Comparison 2026

VIRI yields 1290.32% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VIRI wins by $2.3960825995340865e+24M in total portfolio value
10 years
VIRI
VIRI
● Live price
1290.32%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.3960825995340865e+24M
Annual income
$2,395,725,921,261,555,500,000,000,000,000.00
Full VIRI calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — VIRI vs SBUX

📍 VIRI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVIRISBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VIRI + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VIRI pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VIRI
Annual income on $10K today (after 15% tax)
$109,677.42/yr
After 10yr DRIP, annual income (after tax)
$2,036,367,033,072,322,200,000,000,000,000.00/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, VIRI beats the other by $2,036,367,033,072,322,200,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VIRI + SBUX for your $10,000?

VIRI: 50%SBUX: 50%
100% SBUX50/50100% VIRI
Portfolio after 10yr
$1.1980412997670432e+24M
Annual income
$1,197,862,960,630,777,700,000,000,000,000.00/yr
Blended yield
99.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

VIRI
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
-882.0
Piotroski
1/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VIRI buys
0
SBUX buys
0
No recent congressional trades found for VIRI or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVIRISBUX
Forward yield1290.32%2.84%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%48.3%
Portfolio after 10y$2.3960825995340865e+24M$167.0K
Annual income after 10y$2,395,725,921,261,555,500,000,000,000,000.00$71,136.45
Total dividends collected$2.3960592593715676e+24M$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusHoldBuy

Year-by-year: VIRI vs SBUX ($10,000, DRIP)

YearVIRI PortfolioVIRI Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$268,765$258,064.52$11,121$420.68+$257.6KVIRI
2$13,251,799$12,964,221.46$12,548$648.40+$13.24MVIRI
3$1,208,980,447$1,194,801,021.45$14,440$1,013.98+$1208.97MVIRI
4$205,038,263,945$203,744,654,866.63$17,068$1,617.30+$205038.25MVIRI
5$64,806,832,428,888$64,587,441,486,467.30$20,912$2,649.52+$64806832.41MVIRI
6$38,226,866,599,812,776$38,157,523,289,113,870.00$26,875$4,499.29+$38226866599.79MVIRI
7$42,111,076,145,403,994,000$42,070,173,398,142,190,000.00$36,771$8,014.12+$42111076145403.96MVIRI
8$86,671,038,474,809,380,000,000$86,625,979,623,333,790,000,000.00$54,542$15,197.11+$86671038474809392.00MVIRI
9$333,344,179,935,764,700,000,000,000$333,251,441,924,596,600,000,000,000.00$89,602$31,242.49+$333344179935764676608.00MVIRI
10$2,396,082,599,534,086,500,000,000,000,000$2,395,725,921,261,555,500,000,000,000,000.00$167,011$71,136.45+$2.3960825995340865e+24MVIRI

VIRI vs SBUX: Complete Analysis 2026

VIRIStock

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.

Full VIRI Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this VIRI vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VIRI vs SCHDVIRI vs JEPIVIRI vs OVIRI vs KOVIRI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.